Table 1.
Reference | Formulation | Pharmacokinetic parameter | |||
---|---|---|---|---|---|
C max(ng/L) | t max (h) | AUC (ng/L·h) | t 1/2 (h) | ||
Nonfasted conditions | |||||
Aubin et al. [16] | M | 320 | 0.9 | ND | ND |
UM | 86 | 3.8 | ND | ND | |
Stolk et al. [17] | M | 322 | 2.7 | 942 | ND |
UM | 108 | 3.3 | 276 | ND | |
Treffel et al. [18] | M | 249 | 1.5 | 890 | 3.2 |
UM | 68 | 3.0 | 272 | 2.2 | |
| |||||
Fasted conditions | |||||
Brodie et al. [19] | M | 177 | 1.6 | 433 | 1.4 |
UM | 19 | 3.4 | 64 | 2.0 | |
[20] | M | 32 | 2.0 | 140 | 1.7 |
LS | 71 | 2.0 | 262 | 2.3 |
AUC: area under the plasma concentration curve; Cmax: maximum plasma concentration; LS: gelatin encapsulated liquid suspension; M: micronized; ND: not described; tmax: time to Cmax; UM: unmicronized.